Fund Holdings — Checkpoint Capital L.P.

Total Portfolio Value:
$214.59M
Total Bought:
$60.16M
Total Sold:
$32.54M
Net Transaction:
+$27.62M
Notable People:
Tony Michael Berta
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
argenx SEADR(ARGX)115,000149,977+34,977$68.06M$82.67M38.52%+$14.61M
Rhythm Pharmaceuticals, Inc.(RYTM)907,2401,060,000+152,760$48.06M$66.98M31.21%+$18.92M
Corcept Therapeutics Incorporated(CORT)5,000343,917+338,917$571.1K$25.24M11.76%+$24.67M
Disc Medicine, Inc.(IRON)243,311265,000+21,689$12.08M$14.03M6.54%+$1.96M
Revolution Medicines, Inc.(RVMD)392,011280,000-112,011$13.86M$10.30M4.80%-$3.56M
Septerna, Inc.(SEPN)824,878586,473-238,405$4.78M$6.20M2.89%+$1.42M
Kymera Therapeutics, Inc.(KYMR)136,605106,991-29,614$3.74M$4.67M2.18%+$930.2K
Protagonist Therapeutics Inc175,18481,311-93,873$8.47M$4.49M2.09%-$3.98M
Cidara Therapeutics Inc104,3800-104,380$2.25M$0—-$2.25M
Immunocore Holdings plcADS(IMCR)9,0110-9,011$267.4K$0—-$267.4K
Rapt Therapeutics Inc109,8300-109,830$134.0K$0—-$134.0K
Soleno Therapeutics Inc172,9020-172,902$12.35M$0—-$12.35M
Stoke Therapeutics, Inc.(STOK)730,7170-730,717$4.86M$0—-$4.86M
TScan Therapeutics, Inc.(TCRX)2,017,6500-2,017,650$2.78M$0—-$2.78M
Page 1 of 1
Checkpoint Capital L.P. — 13F Holdings — Q2 2025 | TickerTrail